Filing Details
- Accession Number:
- 0001437749-20-018340
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-19 16:24:47
- Reporting Period:
- 2020-08-17
- Accepted Time:
- 2020-08-19 16:24:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1389545 | Novabay Pharmaceuticals Inc. | NBY | Pharmaceutical Preparations (2834) | 680454536 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1664299 | Mijia Wu | C/O Novabay Pharmaceuticals, Inc. 2000 Powell Street, Suite 1150 Emeryville CA 94608 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-08-17 | 20,000 | $0.30 | 20,000 | No | 4 | A | Direct | |
Common Stock | Disposition | 2020-08-17 | 20,000 | $1.35 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2020-08-17 | 20,000 | $0.00 | 20,000 | $0.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-05-30 | 2029-05-30 | No | 4 | X | Direct |